Pfizer beats profit forecast, helped by cost cuts

Tue May 1, 2012 4:51pm IST

Related Topics

Stocks

   

REUTERS - Pfizer Inc (PFE.N) reported better-than-expected quarterly earnings as cost controls partly offset plunging sales of its Lipitor cholesterol fighter, now facing competition from cheaper generics.

The largest U.S. drugmaker said on Tuesday that it earned $1.79 billion, or 24 cents per share, in the first quarter. That compared with $2.2 billion, or 28 cents per share, in the year-earlier period when results were hurt by a litigation charge and costs of revamping research operations.

Excluding special items, Pfizer earned 58 cents per share. Analysts, on average, had expected 56 cents per share.

The company's revenue fell 7 percent to $15.41 billion, a bit below Wall Street expectations of $15.47 billion.

(Reporting By Ransdell Pierson)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Drug Pricing

REUTERS SHOWCASE

 G20 Meet

G20 Meet

As G20 chases growth goal, members differ on how to get there   Full Article 

Modi Speaks

Modi Speaks

PM Modi says al Qaeda will fail in India - CNN.  Full Article 

Alibaba Listing

Alibaba Listing

Alibaba surges on massive demand in trading debut  Full Article 

Importing Rice

Importing Rice

Top rice exporter India importing over 100,000 T on temporary supply squeeze.  Full Article 

GSK Fined

GSK Fined

China hands drugmaker GSK record $489 mln fine, sentences executives.  Full Article 

HMT in Demand

HMT in Demand

Fans rush to HMT as watchmaker marks time.  Full Article 

Apple Not Cool?

Apple Not Cool?

Some consumers say Apple is losing its "cool" factor  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage